We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+17%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.33B
AUM Growth
+$1.78B
(+24%)
Cap. Flow
+$552M
Cap. Flow
% of AUM
5.91%
Top 10 Holdings %
Top 10 Hldgs %
20.52%
Holding
814
New
78
Increased
378
Reduced
271
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$50.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$39.4M |
| 3 |
Intel
INTC
|
+$29.2M |
| 4 |
Qualcomm
QCOM
|
+$27.6M |
| 5 |
Danaher
DHR
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
+$49.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$41.6M |
| 3 |
ARQL
Arqule Inc
ARQL
|
+$26.5M |
| 4 |
Arrowhead Research
ARWR
|
+$24.9M |
| 5 |
Merck
MRK
|
+$15.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.73% |
| 2 | Technology | 19.55% |
| 3 | Financials | 10.18% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VER
626
DELISTED
VEREIT, Inc.
VER
| $1.18M | 0.01% |
25,439
+8,432
| +50% | +$404K |
|
627
Flowserve
FLS
$9.25B
| $1.17M | 0.01% |
23,542
-41,123
| -64% | -$1.97M |
|
628
Fidelity National Financial
FNF
$13.9B
| $1.17M | 0.01% |
26,796
+2,289
| +9% | +$102K |
|
629
NNN REIT
NNN
$9.39B
| $1.14M | 0.01% |
21,218
+3,776
| +22% | +$210K |
|
630
Regency Centers
REG
$15B
| $1.14M | 0.01% |
18,040
+1,770
| +11% | +$116K |
|
|
HDS
631
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.14M | 0.01% |
+28,299
| New | +$1.13M |
|
632
MarketAxess Holdings
MKTX
$4.15B
| $1.14M | 0.01% |
2,996
+491
| +20% | +$180K |
|
633
Canadian Natural Resources
CNQ
$96.9B
| $1.12M | 0.01% |
70,727
-22,427
| -24% | -$305K |
|
634
AngioDynamics
ANGO
$562M
| $1.12M | 0.01% |
70,000
| – | – |
|
635
Fox Class A
FOXA
$23.2B
| $1.12M | 0.01% |
30,166
-962
| -3% | -$32.9K |
|
636
Sun Communities
SUI
$15B
| $1.1M | 0.01% |
7,325
+1,463
| +25% | +$228K |
|
637
FMC
FMC
$1.42B
| $1.08M | 0.01% |
10,834
-48
| -0.4% | -$4.46K |
|
|
LSXMK
638
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $1.08M | 0.01% |
29,494
+35
| +0.1% | +$1.22K |
|
639
Diageo
DEO
$46.2B
| $1.07M | 0.01% |
+6,369
| New | +$1.04M |
|
640
Targa Resources
TRGP
$60.4B
| $1.07M | 0.01% |
26,239
+290
| +1% | +$11.3K |
|
641
Howmet Aerospace
HWM
$116B
| $1.07M | 0.01% |
45,188
+593
| +1% | +$13.2K |
|
642
Mitsubishi UFJ Financial
MUFG
$258B
| $1.05M | 0.01% |
+193,625
| New | +$1.02M |
|
643
CarMax
KMX
$8.27B
| $1.03M | 0.01% |
11,799
-1,052
| -8% | -$99K |
|
644
Kodiak Sciences
KOD
$2.59B
| $1.03M | 0.01% |
14,347
-240,153
| -94% | -$8.74M |
|
645
Assurant
AIZ
$13.7B
| $1.03M | 0.01% |
7,868
-3,721
| -32% | -$479K |
|
646
Canadian Pacific Kansas City
CP
$82B
| $1.03M | 0.01% |
20,195
-6,320
| -24% | -$296K |
|
647
Lamb Weston
LW
$6.82B
| $1.03M | 0.01% |
11,988
-129,683
| -92% | -$10.4M |
|
648
HDFC Bank
HDB
$119B
| $1.01M | 0.01% |
+32,000
| New | +$974K |
|
649
Burlington
BURL
$22B
| $1.01M | 0.01% |
4,416
-44
| -1% | -$9.2K |
|
650
Bunge Global
BG
$23.6B
| $1.01M | 0.01% |
17,484
-1,084
| -6% | -$60K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2019 Portfolio in Review
As of Q4 2019, Candriam SCA held 814 positions worth $9.33B, up 24% from $7.55B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Candriam SCA deployed $552M of net new capital in Q4 2019, opening 78 new positions and adding to 378 existing holdings. Its largest new stake was Vipshop: 2,005,000 shares worth $28.4M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Ra Pharmaceuticals, Inc. Common Stock, an estimated $49.9M trimmed.
- Candriam SCA's largest Q4 2019 buy was Vipshop: 2,005,000 shares worth $28.4M.
- Candriam SCA added most to Microsoft in Q4 2019, an estimated $50.3M increase.
- Candriam SCA's biggest Q4 2019 reduction was Ra Pharmaceuticals, Inc. Common Stock, cutting an estimated $49.9M.
- Candriam SCA fully exited Hilton Worldwide in Q4 2019, selling an estimated $11.8M.
- Candriam SCA's ten largest holdings make up 21% of its $9.33B portfolio in Q4 2019.
- Candriam SCA opened 78 new positions and closed 33 in Q4 2019.
- Candriam SCA's portfolio value rose 24% quarter-over-quarter to $9.33B.
Based on Candriam SCA's 13F filing for Q4 2019, filed 21 Jan 2020.